Avalon Pharma Signs Cooperation Agreement with King Saud University to Strengthen Academic Partnerships and Community Initiatives

2025-10-10

CSR

In a move that underscores Avalon Pharma’s commitment to fostering institutional partnerships and supporting the private sector’s community role, the company has signed a cooperation agreement with King Saud University (KSU), represented by the Community Relations Office. The agreement aims to enhance academic collaboration and develop joint initiatives in the fields of corporate social responsibility, research, and development.

The agreement was signed by Mr. Hamoud Al-Anzi, Chief Executive Officer of Administrative Affairs at Avalon Pharma, and Prof. Mubarak Al-Qahtani, representing the Acting President of King Saud University, Prof. Ali bin Mohammed Mosmali.

This collaboration forms part of Avalon Pharma’s strategic vision to empower knowledge and foster innovation through effective partnerships between the academic and private sectors, contributing to the goals of Saudi Vision 2030 by advancing research, development, and national talent growth.


Stay informed about the future of healthcare

Visit our newsroom today to stay up to date.